Ajax-Loading

Johnson & Johnson - Cash and Equivalents

Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Cash-and-Equivalents" stands at 5.30 Billion United States Dollars as of 09/30/2025.

As of the end of Johnson & Johnson's third quarter, the item "Cash and Equivalents" stands at 5.30 Billion USD. This represents an increase of 14.25 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 9.28 percent compared to the value the year prior.
The 1 year change in percent is 9.28.
The 3 year change in percent is 249.47.
The 5 year change in percent is -72.06.
The 10 year change in percent is -61.16.

The Serie's long term average value is 13.88 Billion United States Dollars. It's latest available value, on 09/30/2025, is 61.84 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is +249.47%.
The Serie's change in percent from it's maximum value, on 03/31/2012, to it's latest available value, on 09/30/2025, is -82.50%.

Cash and Equivalents for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Cash and Equivalents905,699,262,464.00
LogoAbbVie Inc - Cash and Equivalents399,570,305,024.00
LogoRoche Holding AG - Cash and Equivalents317,433,206,677.55
LogoAstraZeneca PLC - Cash and Equivalents280,205,508,085.11
LogoNovartis AG - Cash and Equivalents255,096,620,580.91